Surgical Reduction and Osteotomy for DDH

Treatment for Congenital musculoskeletal and limb anomalies

Typical Dosage: Single surgical procedure

Effectiveness
90%
Safety Score
58%
Clinical Trials
150
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
58
DangerousModerateSafe
Treatment Details
Dosage Range
Single surgical procedure
Time to Effect
Immediate anatomical correction, recovery 3-6 months
Treatment Duration
One-time surgery, followed by casting for 6-12 weeks, then bracing
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$2,000
Side Effect Mgmt:$800
Total Annual:$20,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATE
ICER
$100,000/QALY
QALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$22,222.22
Cost per Remission
$25,000
Comparison vs Pavlik Harness
Cost Difference
+$19,150/year
More expensive
QALY Difference
-0.20 QALYs
Worse outcomes
Dominance
No dominance
Surgical Reduction and Osteotomy for DDH Outcomes

for Congenital musculoskeletal and limb anomalies

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+80%
Common Side Effects
Infection
+3%
Blood loss
+5%
Nerve injury (rare)
+1%
Avascular necrosis of femoral head
+5%
Residual dysplasia/re-dislocation
+8%

Sources:

mdpub.net
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov